Forvia (FRVIA) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
18 Dec, 2025Executive summary
2024 sales reached €27.2bn, up 0.4% organically, outperforming a 1.1% decline in global auto production, with resilient performance despite challenging macroeconomic and industry conditions.
Strong order intake of €31bn, with significant growth in Asia, robust partnerships with Chinese OEMs, and momentum in electronics.
Net debt reduced by €0.4bn in 2024, with net debt/Adjusted EBITDA at 1.97x, supported by disposals and cash flow.
Accelerated cost reduction and synergies, notably through the EU-FORWARD plan and HELLA integration, with ~2,900 headcount reduction in 2024.
Maintained strong commitment to sustainability, achieving significant CO2 reductions and improved ESG ratings.
Financial highlights
Sales reached €27.2bn, at the upper end of guidance, with 0.4% organic growth year-over-year despite a 1.1% decline in global automotive production.
Operating margin at 5.2% of sales, stable year-over-year, with operating income of €1.4bn.
Net cash flow of €655m, above guidance, supported by capex reduction and inventory management.
Net loss of €185m, mainly due to increased restructuring costs and non-recurring items.
Capex reduced by €164m to €973m (3.6% of sales), and adjusted EBITDA rose 0.8% to €3,355m (12.4% of sales).
Outlook and guidance
2025 sales expected between €26.3bn–€27.5bn, with operating margin guidance of 5.2%–6.0%.
Net cash flow targeted at or above 2024 level (€655m), with further deleveraging to ≤1.8x by end-2025 and below 1.5x in 2026.
No dividend proposed for 2025 to support balance sheet restoration and deleveraging.
Continued focus on asset disposals, operational excellence, and innovation.
Market assumptions: flat global light vehicle production, with regional disparities and continued unfavorable geographic mix in H1.
Latest events from Forvia
- 2024 outlook cut; accelerated cost and China growth actions target stronger 2025 results.FRVIA
Guidance10 Mar 2026 - Margin gains, strong cash flow, and portfolio reshaping set the stage for future growth.FRVIA
Q4 2025 & CMD24 Feb 2026 - Operating margin and cash flow rose, guidance confirmed despite SYMBIO-related net loss.FRVIA
Q2 20253 Feb 2026 - 2.7% organic sales growth, margin gains, and deleveraging progress marked H1 2024.FRVIA
Q2 20243 Feb 2026 - Q3 sales outperformed the market by 420bps, with strong order intake and margin focus.FRVIA
Q3 202419 Jan 2026 - Q1 2025 sales up 2.6% to €6.7bn, 2025 guidance confirmed amid market volatility.FRVIA
Q1 202525 Dec 2025 - Resilient results, new CEO, and strategic focus on sustainability and deleveraging highlighted.FRVIA
AGM 202520 Nov 2025 - Stable Q3 sales and strong cost discipline support confirmed 2025 guidance amid mixed segment trends.FRVIA
Q3 202520 Oct 2025